Skip to main content
SpringerLink
Log in

Blue Dye for Sentinel Lymph Node Mapping: Not Too Sensitive, but Too Hypersensitive?

  • Letter to the Editor
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Leong SPL, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000; 7: 361–6.

    PubMed  CAS  Google Scholar 

  2. Morton DL, Chan AD. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? J Am Coll Surg 1999; 189: 214–23.

    PubMed  CAS  Google Scholar 

  3. Pijpers R, Borgstein PJ, Teule GJ, Meijer S. Vital dye and radiolabeled colloids–complement or alternative? Recent Results Cancer Res 2000; 157: 130–7.

    PubMed  CAS  Google Scholar 

  4. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann. Surg 1996; 223: 217–24.

    PubMed  CAS  Google Scholar 

  5. Kapteijn BA, Nieweg OE, Liem I, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156–60.

    PubMed  CAS  Google Scholar 

  6. Bartolomei M, Testori A, Chinol M, et al. Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping. Eur J Nucl Med 1998; 25: 1489–94.

    PubMed  CAS  Google Scholar 

  7. Bedrosian I, Scheff AM, Mick R, et al. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma [see comments] J Nucl Med 1999; 40: 1143–8.

    PubMed  CAS  Google Scholar 

  8. Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230: 453–63; discussion, 463–5.

    Article  CAS  PubMed  Google Scholar 

  9. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience Ann Surg Oncol 2000; 7: 469–74.

    PubMed  CAS  Google Scholar 

  10. Gennari R, Bartolomei M, Testori A, et al. Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance, Surgery. 2000; 127: 19–25.

    PubMed  CAS  Google Scholar 

  11. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130: 654–8; discussion, 659–60.

    PubMed  CAS  Google Scholar 

  12. Wong JH, Steinemann S, Yonehara C, Coel MN, KoPJ, Tonaki K, Tauchi P. Sentinel node staging for cutaneous melanoma in a university-affiliated community care setting. Ann Surg Oncol 2000; 7: 450–5.

    PubMed  CAS  Google Scholar 

  13. Habib FA, Lodish ME, Mittal VK, Young SC. Sentinel lymph node dissection for primary cutaneous melanoma: a community hospital’s initial experience. Am Surg 2000; 66: 291–5.

    PubMed  CAS  Google Scholar 

  14. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm 1985; 4: 219–21

    PubMed  CAS  Google Scholar 

  15. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217–24.

    PubMed  CAS  Google Scholar 

  16. Kapteijn BA, Nieweg OE, Liem I, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156–60.

    PubMed  CAS  Google Scholar 

  17. Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666–73.

    PubMed  CAS  Google Scholar 

  18. Leong SPL, Morita ET, Treseler PA, Wong JH. Multidisciplinary approach to selective sentinel lymph node mapping in breast cancer. Breast Can 2000; 7: 105–13.

    Article  CAS  Google Scholar 

  19. Leong SPL, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000; 7: 361–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, City of Hope National Cancer Center, Duarte, California

    Robert S. Krouse M.D. & Roderich E. Schwarz M.D.

  2. University of California San, Francisco

    Stanley P. L. Leong MD (Professor of Surgery)

Authors
  1. Robert S. Krouse M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roderich E. Schwarz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stanley P. L. Leong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krouse, R.S., Schwarz, R.E. & Leong, S.P.L. Blue Dye for Sentinel Lymph Node Mapping: Not Too Sensitive, but Too Hypersensitive?. Ann Surg Oncol 8, 268–269 (2001). https://doi.org/10.1007/s10434-001-0268-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0268-1

Keywords

Search

Navigation